FrancophonIA/ELRC3.0 huggingface dataset:
English: - Hyperkinesia (increased movements and inability to keep still) - Weight increase - Allergic reactions (e.g. rash, itching, hypersensitivity) - Fainting - Cardiac failure (heart problems which can cause shortness of breath or ankle swelling)* - Inappropriate antidiuretic hormone secretion* - Restlessness - Dyspnoea (difficulties to breathe) - Hiccups - Pneumonia (infection of the lungs) - Inability to resist the impulse, drive or temptation to perform an action that could be harmful to you or others, which may include:
Norwegian Bokmål: hudutslett, kløe, overfølsomhet) - besvimelse - hjertesvikt (hjerteproblemer som kan føre til kortpustethet eller hevelse i anklene)* - uhensiktsmessig forhøyet sekresjon av antidiuretisk hormon (SIADH)* - rastløshet - dyspné (åndenød) - hikke - lungebetennelse - ute av stand til å motstå impulsen, drivkraften eller fristelsen til å utføre en handling som kan være skadelig for deg selv og andre, slik som:
English: Oprymea 0.088 mg tablets Pramipexole
Norwegian Bokmål: Oprymea 0,088 mg tabletter Pramipexol
English: 2 tablets Oprymea 0.18 mg three times a day
Norwegian Bokmål: 2 tabletter Oprymea 0,18 mg 3ganger daglig
English: White, oval, with bevelled edges, both sides scored, with imprint "P7" on both halves of one side of the tablet.
Norwegian Bokmål: Hvit, oval, med skråkanter, delestrek på begge sider, merket "P7" på begge halvparter på den ene siden av tabletten.
English: White, oval, with bevelled edges, both sides scored, with imprint "P8" on both halves of one side of the tablet.
Norwegian Bokmål: Hvit, oval, med skråkanter, delestrek på begge sider, merket "P8" på begge halvparter på den ene siden av tabletten.
English: Very rare may affect up to 1 in 10,000 people
Norwegian Bokmål: kan forekomme hos opp til 1 av 10 000 personer
English: Thereafter the dose should be reduced by 0.264 mg of base (0.375 mg of salt) per day (see section 4.4).
Norwegian Bokmål: Deretter bør dosen reduseres med 0,264 mg pramipexol base (0,375 mg salt) pr. dag (se pkt.
English: 1 tablet Oprymea 0.088 mg three times a day
Norwegian Bokmål: 1 tablett Oprymea 0,088 mg 3 ganger daglig
English: Superiority of pramipexole prolonged-release tablets over placebo was demonstrated after 18 weeks of treatment on both the primary (UPDRS Parts II+III score) and the key secondary (CGI-I and PGI-I responder rates) efficacy endpoints in a double-blind placebo-controlled trial including a total of 539 patients with early Parkinson's disease.
Norwegian Bokmål: Etter 18 ukers behandling i en dobbeltblind, placebokontrollert studie som inkluderte totalt 539 pasienter med Parkinsons sykdom i tidlig fase, hadde pramipexol depottabletter bedre effekt enn placebo både på primære (UPDRS Parts II+III score) og de viktigste sekundære (CGI-I og PGI-I responderrater) effektendepunktene.
English: Uncommon may affect up to 1 in 100 people
Norwegian Bokmål: kan forekomme hos opp til 1 av 100 personer
English: Focus Care Pharmaceuticals B.V. Tel: +31 (0)75 612 05 11
Norwegian Bokmål: Tel: + 31 (0)75 612 05 11
English: Thereafter the dose should be reduced by 0.26 mg of base (0.375 mg of salt) per day (see section 4.4).
Norwegian Bokmål: Deretter bør dosen reduseres med 0,26 mg pramipexol base (0,375 mg salt) pr. dag (se pkt.
English: White, round, with bevelled edges, both sides scored, with imprint "P9" on both halves of one side of the tablet.
Norwegian Bokmål: Hvit, rund, med skråkanter, delestrek på begge sider, merket "P9" på begge halvparter på den ene siden av tabletten.
English: Oprymea 3.15 mg prolonged-release tablets are white or almost white, round (diameter 10 mm), slightly biconvex tablets engraved with P5 on one side and 315 on the other side, with bevelled edges and possible spots.
Norwegian Bokmål: Oprymea 3,15 mg depottabletter er hvite eller nesten hvite, runde (10 mm i diameter), svakt bikonvekse tabletter inngravert med P5 på den ene siden og 315 på den andre siden, med skråkanter og mulige flekker.
English: Not known: - After stopping or reducing your Oprymea treatment: Depression, apathy, anxiety, fatigue,
Norwegian Bokmål: Ikke kjent: - Etter avsluttet eller nedtrappet Oprymea-behandling: Depresjon, apati, angst, utmattelse, svette eller smerter kan forekomme (kalles dopaminagonist seponeringssyndrom eller DAWS).
English: Oprymea 0.7 mg tablets Each tablet contains 0.7 mg pramipexole (as 1 mg pramipexole dihydrochloride monohydrate).
Norwegian Bokmål: Oprymea 0,7 mg tabletter Hver tablett inneholder 0,7 mg pramipexol (tilsvarende 1 mg pramipexoldihydrokloridmonohydrat).
English: Each tablet contains 0.088 mg pramipexole (as 0.125 mg pramipexole dihydrochloride monohydrate).
Norwegian Bokmål: Hver tablett inneholder 0,088 mg pramipexol (tilsvarende 0,125 mg pramipexoldihydrokloridmonohydrat).
English: If you have advanced Parkinson's disease and are also taking levodopa, you might develop dyskinesia during the uptitration of Oprymea - Dystonia (inability of keeping your body and neck straight and upright (axial dystonia)).
Norwegian Bokmål: Hvis du har avansert Parkinsons sykdom og også tar levodopa, kan du få dyskinesier ved opptrapping av Oprymeadosen.
English: Oprymea 1.05 mg: Each prolonged-release tablet contains 1.05 mg pramipexole (as 1.5 mg pramipexole dihydrochloride monohydrate).
Norwegian Bokmål: Oprymea 1,05 mg: Hver depottablett inneholder 1,05 mg pramipexol (tilsvarende 1,5 mg pramipexoldihydrokloridmonohydrat).
English: Oprymea 0.7 mg tablets Pramipexole
Norwegian Bokmål: Oprymea 0,7 mg tabletter Pramipexol
English: Oprymea 0.26 mg prolonged-release tablets Oprymea 0.52 mg prolonged-release tablets Oprymea 1.05 mg prolonged-release tablets Oprymea 1.57 mg prolonged-release tablets Oprymea 2.1 mg prolonged-release tablets Oprymea 2.62 mg prolonged-release tablets Oprymea 3.15 mg prolonged-release tablets
Norwegian Bokmål: Oprymea 0,26 mg depottabletter Oprymea 0,52 mg depottabletter Oprymea 1,05 mg depottabletter Oprymea 1,57 mg depottabletter Oprymea 2,1 mg depottabletter Oprymea 2,62 mg depottabletter Oprymea 3,15 mg depottabletter
English: If a further dose increase is necessary the daily dose should be increased by 0.54 mg of base (0.75 mg of salt) at weekly intervals up to a maximum dose of 3.3 mg of base (4.5 mg of salt) per day.
Norwegian Bokmål: Hvis en ytterligere doseøkning er nødvendig, bør døgndosen økes med 0,54 mg av pramipexol basen (0,75 mg salt) ukentlig opp til maksimal døgndose på 3,3 mg pramipexol base (4,5 mg salt).
English: Most hallucinations are visual - Dyskinesia (e.g. abnormal, uncontrolled movements of the limbs).
Norwegian Bokmål: - dyskinesier (dvs. unormale, ufrivillige bevegelser av armer eller ben).
English: White or almost white, round (diameter 10 mm), slightly biconvex tablets engraved with P5 on one side and 315 on the other side, with bevelled edges and possible spots.
Norwegian Bokmål: Hvite eller nesten hvite, runde (10 mm i diameter), svakt bikonvekse tabletter inngravert med P5 på den ene siden og 315 på den andre siden, med skråkanter og mulige flekker.
English: Oprymea 2.62 mg prolonged-release tablets Pramipexole
Norwegian Bokmål: Oprymea 2,62 mg depottabletter Pramipexol
English: Not known: - After stopping or reducing your Opymea treatment: Depression, apathy, anxiety, fatigue,
Norwegian Bokmål: Ikke kjent: - Etter avsluttet eller nedtrappet Opyrmea-behandling: Depresjon, apati, angst, utmattelse, svette eller smerter kan forekomme (kalles dopaminagonist seponeringssyndrom eller DAWS).
English: White or almost white, round (diameter 10 mm), slightly biconvex tablets engraved with P13 on one side and 262 on the other side, with bevelled edges and possible spots.
Norwegian Bokmål: Hvite eller nesten hvite, runde (10 mm i diameter), svakt bikonvekse tabletter inngravert med P13 på den ene siden og 262 på den andre siden, med skråkanter og mulige flekker.
English: If a further dose increase is necessary the daily dose should be increased by 0.52 mg of base (0.75 mg of salt) at weekly intervals up to a maximum dose of 3.15 mg of base (4.5 mg of salt) per day.
Norwegian Bokmål: Hvis en ytterligere doseøkning er nødvendig, bør døgndosen økes med 0,52 mg av pramipexol basen (0,75 mg salt) ukentlig opp til maksimal døgndose på 3,15 mg pramipexol base (4,5 mg salt).
English: Tell your doctor if you have or have had or develop any medical conditions or symptoms, especially any of the following: - Kidney disease - Hallucinations (seeing, hearing or feeling things that are not there).
Norwegian Bokmål: Informer legen din dersom du har eller har hatt eller får medisinske tilstander eller symptomer, spesielt noen av de følgende: - nyresykdom.
English: Oprymea 0.18 mg tablets Pramipexole
Norwegian Bokmål: Oprymea 0,18 mg tabletter Pramipexol
English: Each prolonged-release tablet contains 2.62 mg pramipexole (as 3.75 mg pramipexole dihydrochloride monohydrate).
Norwegian Bokmål: Hver depottablett inneholder 2,62 mg pramipexol (tilsvarende 3,75 mg pramipexoldihydrokloridmonohydrat).
English: - Sleepiness and episodes of suddenly falling asleep - Psychosis (e.g. comparable with symptoms of schizophrenia)
Norwegian Bokmål: - psykose (for eksempel symptomer som linger på schizofreni).
English: Dopamine agonist withdrawal syndrome including apathy, anxiety, depression, fatigue, sweating and pain
Norwegian Bokmål: Generelle lidelser og reaksjoner på administrasjonsstedet utmattelse perifert ødem dopaminagonist seponeringssyndrom inkludert apati, angst, depresjon, utmattelse, svetting og smerte
English: Oprymea 0.52 mg: Each prolonged-release tablet contains 0.52 mg pramipexole (as 0.75 mg pramipexole dihydrochloride monohydrate).
Norwegian Bokmål: Oprymea 0,52 mg: Hver depottablett inneholder 0,52 mg pramipexol (tilsvarende 0,75 mg pramipexoldihydrokloridmonohydrat).
English: Oprymea 0.26 mg: Each prolonged-release tablet contains 0.26 mg pramipexole (as 0.375 mg pramipexole dihydrochloride monohydrate).
Norwegian Bokmål: Oprymea 0,26 mg: Hver depottablett inneholder 0,26 mg pramipexol (tilsvarende 0,375 mg pramipexoldihydrokloridmonohydrat).
English: You should have regular eye examinations during treatment with Oprymea - Severe heart or blood vessels disease.
Norwegian Bokmål: - synsforstyrrelser Øynene bør undersøkes regelmessig ved behandling med Oprymea.
English: Oprymea 0.26 mg Oprymea 0.52 mg Oprymea 1.05 mg prolonged-release tablets
Norwegian Bokmål: Oprymea 0,26 mg Oprymea 0,52 mg Oprymea 1,05 mg depottabletter
English: - 7 prolonged-release tablets of 0.52 mg
Norwegian Bokmål: - 7 depottabletter à 0,52 mg
English: Oprymea 0.26 mg Oprymea 0.52 mg Oprymea 1.05 mg prolonged-release tablets Pramipexole
Norwegian Bokmål: Oprymea 0,26 mg Oprymea 0,52 mg Oprymea 1,05 mg depottabletter Pramipexol
English: 1 tablet Oprymea 0.35 mg and 1 tablet Oprymea 0.18 mg
Norwegian Bokmål: 1 tablett Oprymea 0,35 mg og 1 tablett 0,18 mg ELLER 3 tabletter Oprymea 0,18 mg ELLER 6 tabletter Oprymea 0,088 mg
English: Oprymea 2.62 mg prolonged-release tablets
Norwegian Bokmål: Oprymea 2,62 mg depottabletter
English: Each tablet contains 1.1 mg pramipexole (as 1.5 mg pramipexole dihydrochloride monohydrate).
Norwegian Bokmål: Hver tablett inneholder 1,1 mg pramipexol (tilsvarende 1,5 mg pramipexoldihydrokloridmonohydrat).
English: 0.26 mg: White or almost white, round (diameter 10 mm), slightly biconvex tablets engraved with P1 on one side, with bevelled edges and possible spots.
Norwegian Bokmål: 0,26 mg: Hvite eller nesten hvite, runde (10 mm i diameter), svakt bikonvekse tabletter inngravert med P1 på den ene siden, med skråkanter og mulige flekker.
English: 1 tablet Oprymea 0.18 mg three times a day OR
Norwegian Bokmål: 1 tablett Oprymea 0,18 mg 3 ganger daglig
English: 1.05 mg: White or almost white, round (diameter 10 mm), slightly biconvex tablets engraved with P3 on one side, with bevelled edges and possible spots.
Norwegian Bokmål: 1,05 mg: Hvite eller nesten hvite, runde (10 mm i diameter), svakt bikonvekse tabletter inngravert med P3 på den ene siden, med skråkanter og mulige flekker.
English: Each tablet contains 0.7 mg pramipexole (as 1 mg pramipexole dihydrochloride monohydrate).
Norwegian Bokmål: Hver tablett inneholder 0,7 mg pramipexol (tilsvarende 1 mg pramipexoldihydrokloridmonohydrat).
English: Each tablet contains 0.35 mg pramipexole (as 0.5 mg pramipexole dihydrochloride monohydrate).
Norwegian Bokmål: Hver tablett inneholder 0,35 mg pramipexol (tilsvarende 0,5 mg pramipexoldihydrokloridmonohydrat).
English: Each prolonged-release tablet contains 3.15 mg pramipexole (as 4.5 mg pramipexole dihydrochloride monohydrate).
Norwegian Bokmål: Hver depottablett inneholder 3,15 mg pramipexol (tilsvarende 4,5 mg pramipexoldihydrokloridmonohydrat).
English: Oprymea 0.35 mg tablets 20 tablets: EU/1/08/469/011 30 tablets: EU/1/08/469/012 60 tablets: EU/1/08/469/013 90 tablets: EU/1/08/469/014 100 tablets: EU/1/08/469/015
Norwegian Bokmål: Oprymea 0,35 mg tabletter 20 tabletter: EU/1/08/469/011 30 tabletter: EU/1/08/469/012 60 tabletter: EU/1/08/469/013 90 tabletter: EU/1/08/469/014 100 tabletter: EU/1/08/469/015
English: Oprymea 1.1 mg tablets 20 tablets: EU/1/08/469/021 30 tablets: EU/1/08/469/022 60 tablets: EU/1/08/469/023 90 tablets: EU/1/08/469/024 100 tablets: EU/1/08/469/025
Norwegian Bokmål: Oprymea 1,1 mg tabletter 20 tabletter: EU/1/08/469/021 30 tabletter: EU/1/08/469/022 60 tabletter: EU/1/08/469/023 90 tabletter: EU/1/08/469/024 100 tabletter: EU/1/08/469/025
English: Each prolonged-release tablet contains 1.57 mg pramipexole (as 2.25 mg pramipexole dihydrochloride monohydrate).
Norwegian Bokmål: Hver depottablett inneholder 1,57 mg pramipexol (tilsvarende 2,25 mg pramipexoldihydrokloridmonohydrat).
English: Each prolonged-release tablet contains 2.1 mg pramipexole (as 3 mg pramipexole dihydrochloride monohydrate).
Norwegian Bokmål: Hver depottablett inneholder 2,1 mg pramipexol (tilsvarende 3 mg pramipexoldihydrokloridmonohydrat).
English: Oprymea 3.15 mg prolonged-release tablets
Norwegian Bokmål: Oprymea 3,15 mg depottabletter
English: 0.52 mg: White or almost white, round (diameter 10 mm), slightly biconvex tablets engraved with P2 on one side, with bevelled edges and possible spots.
Norwegian Bokmål: 0,52 mg: Hvite eller nesten hvite, runde (10 mm i diameter), svakt bikonvekse tabletter inngravert med P2 på den ene siden, med skråkanter og mulige flekker.
English: Each tablet contains 0.18 mg pramipexole (as 0.25 mg pramipexole dihydrochloride monohydrate).
Norwegian Bokmål: Hver tablett inneholder 0,18 mg pramipexol (tilsvarende 0,25 mg pramipexoldihydrokloridmonohydrat).
English: Oprymea 3.15 mg prolonged-release tablets Pramipexole
Norwegian Bokmål: Oprymea 3,15 mg depottabletter Pramipexol
English: EU/1/08/469/011 [20 tablets] EU/1/08/469/012 [30 tablets] EU/1/08/469/013 [60 tablets] EU/1/08/469/014 [90 tablets] EU/1/08/469/015 [100 tablets]
Norwegian Bokmål: EU/1/08/469/011 [20 tabletter] EU/1/08/469/012 [30 tabletter] EU/1/08/469/013 [60 tabletter] EU/1/08/469/014 [90 tabletter] EU/1/08/469/015 [100 tabletter]
English: EU/1/08/469/021 [20 tablets] EU/1/08/469/022 [30 tablets] EU/1/08/469/023 [60 tablets] EU/1/08/469/024 [90 tablets] EU/1/08/469/025 [100 tablets]
Norwegian Bokmål: EU/1/08/469/021 [20 tabletter] EU/1/08/469/022 [30 tabletter] EU/1/08/469/023 [60 tabletter] EU/1/08/469/024 [90 tabletter] EU/1/08/469/025 [100 tabletter]
English: Oprymea 2.1 mg prolonged-release tablets are white or almost white, round (diameter 10 mm), slightly biconvex tablets engraved with P4 on one side, with bevelled edges and possible spots.
Norwegian Bokmål: Oprymea 2,1 mg depottabletter er hvite eller nesten hvite, runde (10 mm i diameter), svakt bikonvekse tabletter inngravert med P4 på den ene siden, med skråkanter og mulige flekker.
English: Oprymea 0.18 mg tablets 20 tablets: EU/1/08/469/006 30 tablets: EU/1/08/469/007 60 tablets: EU/1/08/469/008 90 tablets: EU/1/08/469/009 100 tablets: EU/1/08/469/010
Norwegian Bokmål: Oprymea 0,18 mg tabletter 20 tabletter: EU/1/08/469/006 30 tabletter: EU/1/08/469/007 60 tabletter: EU/1/08/469/008 90 tabletter: EU/1/08/469/009 100 tabletter: EU/1/08/469/010
English: Oprymea 1.57 mg prolonged-release tablets are white or almost white, round (diameter 10 mm), slightly biconvex tablets engraved with P12 on one side, with bevelled edges and possible spots.
Norwegian Bokmål: Oprymea 1,57 mg depottabletter er hvite eller nesten hvite, runde (10 mm i diameter), svakt bikonvekse tabletter inngravert med P12 på den ene siden, med skråkanter og mulige flekker.
English: Oprymea 1.05 mg prolonged-release tablets are white or almost white, round (diameter 10 mm), slightly biconvex tablets engraved with P3 on one side, with bevelled edges and possible spots.
Norwegian Bokmål: Oprymea 1,05 mg depottabletter er hvite eller nesten hvite, runde (10 mm i diameter), svakt bikonvekse tabletter inngravert med P3 på den ene siden, med skråkanter og mulige flekker.
English: Oprymea 3.15 mg prolonged-release tablets 10 prolonged-release tablets: EU/1/08/469/050 30 prolonged-release tablets: EU/1/08/469/051 90 prolonged-release tablets: EU/1/08/469/052 100 prolonged-release tablets: EU/1/08/469/053
Norwegian Bokmål: Oprymea 3,15 mg depottabletter 10 depottabletter: EU/1/08/469/050 30 depottabletter: EU/1/08/469/051 90 depottabletter: EU/1/08/469/052 100 depottabletter: EU/1/08/469/053
English: Oprymea 0.7 mg tablets 20 tablets: EU/1/08/469/016 30 tablets: EU/1/08/469/017 60 tablets: EU/1/08/469/018 90 tablets: EU/1/08/469/019 100 tablets: EU/1/08/469/020
Norwegian Bokmål: Oprymea 0,7 mg tabletter 20 tabletter: EU/1/08/469/016 30 tabletter: EU/1/08/469/017 60 tabletter: EU/1/08/469/018 90 tabletter: EU/1/08/469/019 100 tabletter: EU/1/08/469/020
English: Oprymea 1.05 mg prolonged-release tablets
Norwegian Bokmål: Oprymea 1,05 mg depottabletter
English: Oprymea 1.05 mg prolonged-release tablets 10 prolonged-release tablets: EU/1/08/469/034 30 prolonged-release tablets: EU/1/08/469/035 90 prolonged-release tablets: EU/1/08/469/036 100 prolonged-release tablets: EU/1/08/469/037
Norwegian Bokmål: Oprymea 1,05 mg depottabletter 10 depottabletter: EU/1/08/469/034 30 depottabletter: EU/1/08/469/035 90 depottabletter: EU/1/08/469/036 100 depottabletter: EU/1/08/469/037
English: Doses should be increased gradually from a starting dose of 0.26 mg of base (0.375 mg of salt) per day and then increased every 5 - 7 days.
Norwegian Bokmål: Dosen økes gradvis hver 5.-7. dag fra en startdose på 0,26 mg pramipexol base (0,375 mg salt) pr. døgn.
English: Each prolonged-release tablet contains 1.05 mg pramipexole (as 1.5 mg pramipexole dihydrochloride monohydrate).
Norwegian Bokmål: Hver depottablett inneholder 1,05 mg pramipexol (tilsvarende 1,5 mg pramipexoldihydrokloridmonohydrat).
English: Oprymea 2.1 mg prolonged-release tablets 10 prolonged-release tablets: EU/1/08/469/042 30 prolonged-release tablets: EU/1/08/469/043 90 prolonged-release tablets: EU/1/08/469/044 100 prolonged-release tablets: EU/1/08/469/045
Norwegian Bokmål: Oprymea 2,1 mg depottabletter 10 depottabletter: EU/1/08/469/042 30 depottabletter: EU/1/08/469/043 90 depottabletter: EU/1/08/469/044 100 depottabletter: EU/1/08/469/045
English: One Oprymea 1.05 mg prolonged-release tablet, OR two Oprymea 0.52 mg prolonged-release tablets, OR four Oprymea 0.26 mg prolonged-release tablets.
Norwegian Bokmål: Én Oprymea 0,26 mg depottablett Én Oprymea 0,52 mg depottablett ELLER to Oprymea 0,26 mg depottabletter Én Oprymea 1,05 mg depottablett ELLER to Oprymea 0,52 mg depottabletter ELLER fire Oprymea 0,26 mg depottabletter
English: EU/1/08/469/001[20 tablets] EU/1/08/469/002 [30 tablets] EU/1/08/469/003 [60 tablets] EU/1/08/469/004 [90 tablets] EU/1/08/469/005 [100 tablets]
Norwegian Bokmål: EU/1/08/469/001 [20 tabletter] EU/1/08/469/002 [30 tabletter] EU/1/08/469/003 [60 tabletter] EU/1/08/469/004 [90 tabletter] EU/1/08/469/005 [100 tabletter]
English: EU/1/08/469/016 [20 tablets] EU/1/08/469/017 [30 tablets] EU/1/08/469/018 [60 tablets] EU/1/08/469/019 [90 tablets] EU/1/08/469/020 [100 tablets]
Norwegian Bokmål: EU/1/08/469/016 [20 tabletter] EU/1/08/469/017 [30 tabletter] EU/1/08/469/018 [60 tabletter] EU/1/08/469/019 [90 tabletter] EU/1/08/469/020 [100 tabletter]
English: Oprymea 2.62 mg prolonged-release tablets 10 prolonged-release tablets: EU/1/08/469/046 30 prolonged-release tablets: EU/1/08/469/047 90 prolonged-release tablets: EU/1/08/469/048 100 prolonged-release tablets: EU/1/08/469/049
Norwegian Bokmål: Oprymea 2,62 mg depottabletter 10 depottabletter: EU/1/08/469/046 30 depottabletter: EU/1/08/469/047 90 depottabletter: EU/1/08/469/048 100 depottabletter: EU/1/08/469/049
English: EU/1/08/469/042 [10 prolonged-release tablets] EU/1/08/469/043 [30 prolonged-release tablets] EU/1/08/469/044 [90 prolonged-release tablets] EU/1/08/469/045 [100 prolonged-release tablets]
Norwegian Bokmål: EU/1/08/469/042 [10 depottabletter] EU/1/08/469/043 [30 depottabletter] EU/1/08/469/044 [90 depottabletter] EU/1/08/469/045 [100 depottabletter]
English: In human volunteers, a dose-dependent decrease in prolactin was observed.
Norwegian Bokmål: En doseavhengig reduksjon i prolaktin er sett hos friske frivillige forsøkspersoner.
English: Oprymea 1.57 mg prolonged-release tablets 10 prolonged-release tablets: EU/1/08/469/038 30 prolonged-release tablets: EU/1/08/469/039 90 prolonged-release tablets: EU/1/08/469/040 100 prolonged-release tablets: EU/1/08/469/041
Norwegian Bokmål: Oprymea 1,57 mg depottabletter 10 depottabletter: EU/1/08/469/038 30 depottabletter: EU/1/08/469/039 90 depottabletter: EU/1/08/469/040 100 depottabletter: EU/1/08/469/041
English: Oprymea 0.52 mg prolonged-release tablets are white or almost white, round (diameter 10 mm), slightly biconvex tablets engraved with P2 on one side, with bevelled edges and possible spots.
Norwegian Bokmål: Oprymea 0,52 mg depottabletter er hvite eller nesten hvite, runde (10 mm i diameter), svakt bikonvekse tabletter inngravert med P2 på den ene siden, med skråkanter og mulige flekker.
English: Oprymea 1.57 mg prolonged-release tablets
Norwegian Bokmål: Oprymea 1,57 mg depottabletter
English: EU/1/08/469/050 [10 prolonged-release tablets] EU/1/08/469/051 [30 prolonged-release tablets] EU/1/08/469/052 [90 prolonged-release tablets] EU/1/08/469/053 [100 prolonged-release tablets]
Norwegian Bokmål: EU/1/08/469/050 [10 depottabletter] EU/1/08/469/051 [30 depottabletter] EU/1/08/469/052 [90 depottabletter] EU/1/08/469/053 [100 depottabletter]
English: EU/1/08/469/006 [20 tablets] EU/1/08/469/007 [30 tablets] EU/1/08/469/008 [60 tablets] EU/1/08/469/009 [90 tablets] EU/1/08/469/010 [100 tablets]
Norwegian Bokmål: EU/1/08/469/006 [20 tabletter] EU/1/08/469/007 [30 tabletter] EU/1/08/469/008 [60 tabletter] EU/1/08/469/009 [90 tabletter] EU/1/08/469/010 [100 tabletter]
English: EU/1/08/469/034 [10 prolonged-release tablets] EU/1/08/469/035 [30 prolonged-release tablets] EU/1/08/469/036 [90 prolonged-release tablets] EU/1/08/469/037 [100 prolonged-release tablets]
Norwegian Bokmål: EU/1/08/469/034 [10 depottabletter] EU/1/08/469/035 [30 depottabletter] EU/1/08/469/036 [90 depottabletter] EU/1/08/469/037 [100 depottabletter]
English: EU/1/08/469/046 [10 prolonged-release tablets] EU/1/08/469/047 [30 prolonged-release tablets] EU/1/08/469/048 [90 prolonged-release tablets] EU/1/08/469/049 [100 prolonged-release tablets]
Norwegian Bokmål: EU/1/08/469/046 [10 depottabletter] EU/1/08/469/047 [30 depottabletter] EU/1/08/469/048 [90 depottabletter] EU/1/08/469/049 [100 depottabletter]
English: Oprymea 0.52 mg prolonged-release tablets Pramipexole
Norwegian Bokmål: Oprymea 0,52 mg depottabletter Pramipexol
English: Oprymea 1.57 mg prolonged-release tablets Pramipexole
Norwegian Bokmål: Oprymea 1,57 mg depottabletter Pramipexol
English: Oprymea 0.26 mg prolonged-release tablets 10 prolonged-release tablets: EU/1/08/469/026 30 prolonged-release tablets: EU/1/08/469/027 90 prolonged-release tablets: EU/1/08/469/028 100 prolonged-release tablets: EU/1/08/469/029
Norwegian Bokmål: Oprymea 0,26 mg depottabletter 10 depottabletter: EU/1/08/469/026 30 depottabletter: EU/1/08/469/027 90 depottabletter: EU/1/08/469/028 100 depottabletter: EU/1/08/469/029
English: Oprymea 0.52 mg prolonged-release tablets
Norwegian Bokmål: Oprymea 0,52 mg depottabletter